PharmiNews

Directory of Pharma Companies and News

Company Profile

IXALTIS

IXALTIS logo
Category
Ixaltis is a start-up pharmaceutical company specialized in genitourinary and renal diseases. It has acquired the rights to three molecules from Sanofi, and completed a round A of financing in 2016 to develop these compounds further. The company recently launched its first Phase II clinical study for its leading compound Litoxetine IXA-001.
Keywords:
0 results
Brought to you by PharmiWeb.com - Latest Jobs in Pharma